Basilea Pharmaceutica Financial Overview
Basilea Pharmaceutica's market cap is currently CHF568.22M. The company's EPS TTM is CHF1.26; its P/E ratio is 7.80; Basilea Pharmaceutica is scheduled to report earnings on August 19, 2025, and the estimated EPS forecast is CHF1.73. See an overview of income statement, balance sheet, and cash flow financials.
